Author

Jennifer Margrave

Observed name: J. Margrave

Observed institutions: Henry Ford Health, University of Michigan, Henry Ford Hospital

OpenAlex ID: A5001198630

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer

2017 · Daniel E. Spratt, Jingbin Zhang, et al. · Journal of Clinical Oncology · 211

Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer

2021 · Felix Y. Feng, Huei-Chung Huang, et al. · JAMA Oncology · 155

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens

2017 · Paul L. Nguyen, Zaid Haddad, et al. · European Urology · 95

The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer

2018 · Matthew R. Cooperberg, Nicholas Erho, et al. · European Urology · 74

Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery

2019 · Thomas Van den Broeck, Lisa Moris, et al. · European Urology Oncology · 29

The diverse genomic landscape of low-risk prostate cancer.

2017 · Matthew R. Cooperberg, Nicholas Erho, et al. · Journal of Clinical Oncology · 2

The diverse genomic landscape of low−risk prostate cancer.

2018 · Matthew R. Cooperberg, Nicholas Erho, et al. · Journal of Clinical Oncology · 1

Genomic analysis of primary high-risk prostate cancer tumors with metastatic recurrence identifies antizyme inhibitor 1 as a regulator of cancer cell migration through regulation of collagen expression

2018 · T. Van Den Broeck, L. Moris, et al. · European Urology Supplements

Validation of a genomic classifier to predict adverse pathology in men diagnosed with low risk prostate cancer.

2018 · Hyung Lae Kim, Ping Li, et al. · Journal of Clinical Oncology

Pnfba-09 the Diverse Genomic Landscape of Low-risk Prostate Cancer

2017 · Matthew R. Cooperberg, Nicholas Erho, et al. · The Journal of Urology

Mp64-12 Assessing Decipher for Predicting Lymph Node Positive Disease Among Men Diagnosed With Intermediate Risk Disease Treated With Prostatectomy and Eplnd

2017 · Mary Achim, Surena Matin, et al. · The Journal of Urology

A genomic analysis of metastases-prone localized prostate cancer in a European high-risk population

2017 · T. Van Den Broeck, T. Gevaert, et al. · European Urology Supplements

The diverse genomic landscape of low-risk prostate cancer

2017 · M. Cooperberg, N. Erho, et al. · European Urology Supplements

Works count: 13

Citation count: 567

H-index: 5

I10-index: 5